(Q49079204)

English

Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.

scientific article published in April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

coronary artery disease

1 reference

based on heuristic

inferred from title

Jean Dallongeville

3

object named as

Jean Dallongeville

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

4

object named as

Guy De Backer

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

5

object named as

Linda Mellbin

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

1

object named as

Viveca Gyberg

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

6

object named as

Lars Rydén

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

Kornelia Kotseva

2

object named as

Kornelia Kotseva

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

Dirk De Bacquer

8

object named as

Dirk De Bacquer

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

author name string

David Wood

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

EUROASPIRE Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

publication date

1 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

European Journal of Preventive Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

22

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

753-761

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Diabetes, hypertension, and cardiovascular disease: an update

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

2013 ESC guidelines on the management of stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Impact of medication therapy discontinuation on mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised con

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Impact of a computerized system for evidence-based diabetes care on completeness of records: a before-after study.

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

It's time to overcome clinical inertia

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

1 reference

https://api.crossref.org/works/10.1177%2F2047487314529353

21 January 2018

Identifiers

10.1177/2047487314529353

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24691153

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49079204&oldid=2153458417"